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Systemic exposure to the inflammagen and bacterial endotoxin lipopolysaccharide (LPS)
has been widely used to evaluate inflammation and sickness behavior. While many inflammatory conditions occur in the periphery, it is well established that peripheral inflammation
can affect the brain. Neuroinflammation, the elaboration of proinflammatory mediators in the
CNS, commonly is associated with behavioral symptoms (e.g., lethargy, anhedonia,
anorexia, depression, etc.) termed sickness behavior. Stressors have been shown to interact with and alter neuroinflammatory responses and associated behaviors. Here, we examined the effects of the stress hormone, corticosterone (CORT), as a stressor mimic, on
neuroinflammation induced with a single injection (2mg/kg, s.c.) or inhalation exposure
(7.5 μg/m3) of LPS or polyinosinic:polycytidylic acid (PIC; 12mg/kg, i.p.) in adult male
C57BL/6J mice. CORT was given in the drinking water (200 mg/L) for 1 week or every other
week for 90 days followed by LPS. Proinflammatory cytokine expression (TNFα, IL-6, CCL2,
IL-1β, LIF, and OSM) was measured by qPCR. The activation of the neuroinflammation
downstream signaling activator, STAT3, was assessed by immunoblot of pSTAT3Tyr705.
The presence of astrogliosis was assessed by immunoassay of GFAP. Acute exposure to
LPS caused brain-wide neuroinflammation without producing astrogliosis; exposure to
CORT for 1 week caused marked exacerbation of the LPS-induced neuroinflammation. This
neuroinflammatory “priming” by CORT was so pronounced that sub-neuroinflammatory
exposures by inhalation instigated neuroinflammation when paired with prior CORT exposure. This effect also was extended to another common inflammagen, PIC (a viral mimic).
Furthermore, a single week of CORT exposure maintained the potential for priming for 30
days, while intermittent exposure to CORT for up to 90 days synergistically primed the LPSinduced neuroinflammatory response. These findings highlight the possibility for an isolated
inflammatory event to be exacerbated by a temporally distant stressful stimulus and demonstrates the potential for recurrent stress to greatly aggravate chronic inflammatory disorders.
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Introduction
Inflammation can result from acute exposures to pathogens, chemicals, physical damage, irritants, and chronic illnesses. As a component of the innate immune response, inflammation is
characterized by the activation of macrophages and their subsequent release of cytokines.
While many inflammatory conditions occur in the periphery, it has been well established that
peripheral inflammation can exert effects on the brain, as reflected in the enhanced expression
of proinflammatory mediators. Anti-inflammatory compounds can ameliorate these neuroinflammatory responses, as well as systemic inflammation. For example, therapy with the classic
anti-inflammatory rodent glucocorticoid, corticosterone (CORT), can suppress neuroinflammation and neuroinflammatory signaling caused by exposure to neurotoxins or the bacterial
endotoxin, lipopolysaccharide (LPS) [1]. Paradoxically, prior treatment with CORT can
enhance rather than suppress the neuroinflammatory response to neurotoxicants [2], acetylcholinesterase inhibitors [3,4], and LPS [5,6]. These results suggest that glucocorticoids can
either ameliorate or potentiate the response to a neuroinflammagen depending on whether the
treatment occurs before or after an inflammatory exposure.
Increases in plasma cortisol in humans or of CORT in rodents result from stressor exposures. Serum CORT levels frequently are used as indicators of a stress response; accordingly,
exogenous CORT administration can be used to mimic stressor exposures in rodents. Precedent exists for a proinflammatory effect of stress hormones [7,8]. The influence of stressors on
inflammation vary depending on the duration and frequency of the stressor response. Thus,
exposure to acute stressors can either be protective or detrimental to the immune system.
However, repeated exposure to a stressor has been shown to profoundly exacerbate inflammation [7–10]. Several studies utilizing various stressors (such as restraint, social defeat, forced
swim and isolation) in rodent models show exacerbation of the inflammatory response to LPS
after stressor exposure [11–16]. These findings suggest that prolonged or repeated elevations
of CORT may predispose the CNS to a heightened or prolonged neuroinflammatory response.
In this study, we sought to determine if chronic exposure to CORT could produce persistent, LPS-induced neuroinflammation. While several studies have examined the immediate
effects of CORT exposure on neuroinflammation [17–19], here we investigated the effects of a
single, week-long exposure to CORT, as well as recurring exposures to CORT over several
months, on LPS-induced neuroinflammation. These CORT exposure regimens induce a persistent and escalating “priming” of the neuroinflammatory response to LPS, findings suggestive of a role for repeated exposures to stressors in the development of chronic
neuroinflammatory disorders.

Materials and methods
Materials
The following drugs and chemicals were provided by or obtained from the sources indicated:
LPS from Esherichia coli serotype 055:B5 (Cat. Number L2880, Sigma-Aldrich, St. Louis, MO,
USA), polyinosinic:polycytidylic acid (PIC; Invivogen, San Diego, CA, USA), CORT (Steraloids, Inc., Newport, RI, USA). The materials used in the glial fibrillary acidic protein (GFAP)
assay have been described in detail [20,21]. All other reagents and materials were of at least
analytical grade and were obtained from a variety of commercial sources.

Animals
Male C57BL/6J mice (n = 5 mice per group), 4–6 weeks of age were purchased from Jackson
Labs (Bar Harbor, ME, USA). All procedures were performed within protocols approved by
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the Institutional Animal Care and Use Committee of the Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, and the animal colony was certified by the Association for Assessment and Accreditation of Laboratory Animal Care. Upon
receipt, mice were housed individually in a temperature-controlled (21 ± 1˚C) and humiditycontrolled (50 ± 10%) colony room maintained under filtered positive-pressure ventilation on a
12h light/12h dark cycle beginning at 0600. The plastic tub cages were 46 cm in length by 25 cm
in width by 15 cm in height; cage bedding consisted of heat-treated pine shavings spread at a
depth of approximately 4 cm. Food (Harlan 7913 irradiated NIH-31 modified 6% rodent chow)
and water were available ad libitum. The mice in this study were individually housed in order to
correlate with other previously studies evaluating CORT priming of neuroinflammation [2,3,4].

Dosing
For short-term exposures, CORT was given in the drinking water (200 mg/L in 0.6% EtOH) for
1 week prior to LPS, PIC, or vehicle treatment on day 8. This regimen of CORT was chosen
because of its ability to achieve high circulating levels of this hormone, similar to those achieved
with repeated stress [22], and because it was capable of producing significant immunosuppression as evidenced by involution of the thymus (e.g., see O’Callaghan et al., 1991 [23]). LPS was
administered in one of two ways: 1) injected subcutaneously (s.c.) at 2 mg/kg where vehicle was
0.9% saline; or 2) whole body inhalation exposure [24] to aerosolized LPS (7.5 μg/m3)(~7.5 x
104 Endotoxin Units/m3) for 3 hours where vehicle was water. PIC was administered intraperitoneally at 12 mg/kg (0.9% saline vehicle). For 30 or 90 day exposures, CORT was given in the
drinking water (200 mg/L in 0.6% EtOH) for 1 week prior to LPS or vehicle injection on day 37
or 97, respectively. However, for the 90 day CORT +++ exposure, CORT was given in the
drinking water (200 mg/L in 0.6% EtOH) every other week for 13 weeks prior to LPS exposure
on day 97. Mice were killed by decapitation or focused microwave irradiation (see below) at 2,
6, 12, or 72 hours post-LPS or vehicle exposure and 6 hours post-PIC exposure.

Brain dissection and tissue preparation
Immediately after decapitation, whole brains were removed from the skull with the aid of
blunt curved forceps. Striatum, hippocampus, cortex, cerebellum, olfactory bulb, and hypothalamus were dissected free hand on a thermoelectric cold plate (Model TCP-2, Aldrich
Chemical Co., Milwaukee, WI, USA) using a pair of fine curved forceps (Roboz, Washington,
DC, USA). Brain regions from one side of the brain were frozen at -85˚C and used for subsequent isolation of total RNA; brain regions from the other side of the brain were used for total
and specific protein analysis. These regions were weighed and homogenized with a sonic
probe (model XL-2005, Heat Systems, Farmingdale, NY, USA) in 10 volumes of hot (90–95˚C)
1% sodium dodecyl sulfate (SDS), and stored frozen at -70˚C before total protein assay and
immunoassay of GFAP. A separate set of mice were used for phosphorylated signal transducer
and activator of transcription 3 at tyrosine 705 (pSTAT3Tyr705) analysis and were sacrificed by
focused microwave irradiation (Muromachi Kikai, Inc., Tokyo, Japan; Model TMW-4012C,
3.5 KW applied power, 0.90 sec) to preserve steady-state phosphorylation for analysis using
phospho-state-specific antibodies [25]. Microwave-fixed brain regions were processed for protein analysis as described above.

RNA isolation, cDNA synthesis, and real-time PCR amplification
The detailed protocols can be found at protocols.io (DX.DOI.ORG/10.17504/PROTOCOLS.
IO.HTRB6M6; DX.DOI.ORG/10.17504/PROTOCOLS.IO.HTVB6N6; DX.DOI.ORG/10.
17504/PROTOCOLS.IO.HTWB6PE). Total RNA from striatum, hippocampus, cortex,
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cerebellum, olfactory bulb, and hypothalamus was isolated using Trizol1 reagent (Thermo
Fisher Scientific, Waltham, MA, USA) and Phase-lock heavy gel (Eppendorf AG, Hamburg,
Germany). The RNA was further cleaned using RNeasy mini spin columns (Qiagen, Valencia,
CA, USA). Total RNA (1 μg) was reverse transcribed to cDNA using SuperScript™ III and
oligo (dT)12-18 primers (Thermo Fisher Scientific, Waltham, MA, USA) in a 20 μL reaction.
Real-time PCR analysis of the housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), and of the proinflammatory mediators, TNFα, IL-6, CCL2, IL-1β, leukemia inhibitor factor (LIF), and oncostatin M (OSM) was performed in an ABI7500 Real-Time PCR System (Thermo Fisher Scientific, Waltham, MA, USA) in combination with TaqMan1
chemistry. Specific primers and dual-labeled internal fluorogenic (FAM/TAMRA) probe sets
(TaqMan1 Gene Expression Assays) for these genes were procured from Thermo Fisher Scientific (Waltham, MA, USA) and used according to the manufacturer’s recommendations. All
PCR amplifications (40 cycles) were performed in a total volume of 50 μL, containing 1 μL
cDNA, 2.5 μL of the specific assay of demand primer/probe mix, and 25 μL of Taqman1 Universal master mix. Relative quantification of gene expression was performed using the comparative threshold (ΔΔCT) method. Changes in mRNA expression levels were calculated after
normalization to GAPDH. The ratios obtained after normalization are expressed as fold
change over corresponding saline-treated controls.

Protein assay
A detailed protocol can be found at protocols.io (DX.DOI.ORG/10.17504/PROTOCOLS.IO.
HSWB6FE). Total protein was determined using the Pierce BCA Protein Assay Kit (Thermo
Fisher Scientific, Waltham, MA, USA), per the manufacturer’s instructions. Absolute absorbance was measured using the Spectra Max Plus microplate reader and analyzed using Soft
Max Pro Plus software (Molecular Devices, Sunnyvale, CA, USA).

GFAP immunoassay
A detailed protocol can be found at protocols.io (DX.DOI.ORG/10.17504/PROTOCOLS.IO.
HSUB6EW). GFAP was assayed in accordance with a previously described procedure [20,21].
In brief, a rabbit polyclonal antibody to GFAP (1:400; DAKO, Carpenteria, CA, USA) was
coated on the wells of Immulon-2 microtiter plates (Thermo Labsystems, Franklin, MA). The
SDS homogenates and standards were diluted in phosphate-buffered saline (pH 7.4) containing 0.5% Triton X-100. Standards consisted of SDS homogenates of hippocampus with known
concentration of GFAP and were prepared the same way as the samples. After blocking nonspecific binding with 5% non-fat dry milk, aliquots of the homogenate and standards were
added to the wells and incubated. Following washes, a mouse monoclonal antibody to GFAP
(1:250; Sigma Chemical Co., St. Louis, MO, USA) was added to ‘sandwich’ the GFAP between
the two antibodies. An alkaline phosphatase-conjugated antibody directed against mouse IgG
(1:2000; Jackson ImmunoResearch Labs, West Grove, PA, USA) was then added and a colored
reaction product was obtained by subsequent addition of the enzyme substrate p-nitrophenol.
Quantification was achieved by spectrophotometry of the colored reaction product at 405 nm
in the microplate reader (see above), and analyzed with the same software. The amount of
GFAP in the samples was calculated as micrograms of GFAP per milligram total protein.

pSTAT3 immunoblot analysis
A detailed protocol can be found at protocols.io (DX.DOI.ORG/10.17504/PROTOCOLS.IO.
HT4B6QW). Activation of the JAK-STAT3 neuroinflammation effector pathway [1] was
assessed by quantifying pSTAT3Tyr705 from immunoblots with detection of fluorescent signals

PLOS ONE | https://doi.org/10.1371/journal.pone.0190546 January 5, 2018

4 / 18

Corticosterone markedly enhances and prolongs neuroinflammatory response to systemic LPS challenge

using an infrared fluorescence scanner (Licor Biosciences; Lincoln, NE, USA) as described
previously [1,25–27]. Briefly, following incubation with primary antibodies (rabbit anti-phospho-STAT3Tyr705[1:500]; Cell Signaling, Danvers, MA, USA), blots were washed with phosphate buffered saline with 0.1% Tween-20 and incubated with anti-rabbit fluorescent-labeled
secondary antibody (1:2500) for 1h prior to scanning by Licor.

Statistics
Statistical analysis of data was performed utilizing SigmaPlot (v. 11.0). The test of significance
was performed using either one-way ANOVA (Saline x LPS) or two-way ANOVA (pretreatment [Water or CORT] x exposure [Saline or LPS/PIC]) on log transformed values followed by
multiple pairwise comparison analysis using Fisher least significant difference (LSD) post hoc
test with statistical significance at 5% (p<0.05). Graphical representations are mean ± SEM.

Results
Systemic exposure to LPS is neuroinflammatory
Systemic exposure to LPS is known to result in a neuroinflammatory response [1,28–30].
Accordingly, exposure to LPS (2 mg/kg, s.c.) caused a time-dependent increase in expression
of neuroinflammatory cytokines and chemokines in cortex (Fig 1A). Neuroinflammation was
seen with a peak as early as 2 hours post-LPS. In some cases, neuroinflammation persisted to
12 hours after LPS exposure (e.g., TNFα and IL-1β). Overall, the response to LPS occurred
throughout the brain (see Fig 2 below).

Systemic exposure to LPS activates the STAT3 pathway without causing
astrogliosis
IL-6, LIF, and OSM have been shown to bind to the gp130 receptor, with crosstalk input from
the other cytokines/chemokines, and to subsequently activate the janus kinase 2 (JAK2)
/STAT3 pathway (e.g., see O’Callaghan et al., 2014 [1]). Therefore, we evaluated the phosphorylation state of STAT3 at Tyr705 as an index of the downstream activation of the cytokine/
JAK2/STAT3 signaling cascade. In agreement with our prior findings for effects of LPS in striatum [1], pSTAT3Tyr705 was significantly increased 6 hours after LPS exposure in all brain
areas; cortex data are shown as representative of other areas (Fig 1B). This time point corresponds to the period after the onset of enhanced expression of cytokine and chemokine
mRNA (Fig 1A), consistent with activation of STAT3 as a downstream effector of cytokine/
chemokine signaling.
The close association of neuronal damage and neuroinflammation has made it difficult to
separate the two conditions, with many publications inferring that neuroinflammation causes
damage, or vice versa. Astrogliosis, as evidenced by an enhanced expression of GFAP, is a hallmark of toxicant-induced neuronal damage [31]. Previously, we have shown that neuroinflammation precedes the activation of the STAT3 pathway in astrocytes and the subsequent
increase in expression of GFAP that is associated with toxicant-induced damage to dopaminergic nerve terminals [1]. In contrast, LPS-induced neuroinflammation, while activating the
striatal STAT3 pathway, does not result in astrogliosis [1]. In agreement with these latter findings, LPS failed to increase GFAP in cortex (Fig 1C).

Chronic exposure to CORT exacerbates LPS-induced neuroinflammation
Previously, we showed that week-long exposure to CORT enhanced both neuroinflammation
and neurodegeneration in mice exposed to a neurotoxic regimen of methamphetamine [2].
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Fig 1. Systemic LPS exposure is neuroinflammatory but does not induce astrogliosis. A) The effects of LPS (2 mg/kg, s.c.) on TNFα, IL-6, CCL2, IL-1β, LIF, and
OSM mRNA levels in samples prepared from cortex were determined at 2, 6, and 12 hours after LPS exposure. Data represents mean ± SEM (n = 5 mice/group).
Statistical significance of at least p<0.05 is denoted by  as compared to control, # as compared to 2h LPS, and § as compared to 6h LPS. B & C) The effects of LPS
exposure (2 mg/kg, s.c.) on activation of the STAT3 signaling module was assessed by immunoblots of pSTAT3Tyr705 and astrogliosis was assessed by immunoassay
of GFAP. Cortex samples were analyzed for pSTAT3Tyr705 (6 hours) and GFAP (72 hours) after LPS exposure. Data represents mean ± SEM (n = 5 mice/group).
Statistical significance of at least p<0.05 is denoted by  as compared to control.
https://doi.org/10.1371/journal.pone.0190546.g001

Here, we again administered CORT in the drinking water for 1 week and found that the neuroinflammatory response to LPS was markedly exacerbated by CORT; this enhanced neuroinflammatory response to LPS occurred in several brain regions (Fig 2). The exacerbation of
neuroinflammation induced by CORT pretreatment resulted in a longer lasting and more
accentuated response as evidenced by significantly heightened neuroinflammation at 6 and 12
hours after LPS exposure in cortex (Fig 3A) compared to LPS exposure alone (LPS data from
Fig 1A included for statistical comparison).
While prior CORT can enhance neurodegenerative responses seen with a neurotoxicant
such as methamphetamine [2], an effect associated with increased activation of STAT3 and
accompanying astrogliosis, these effects were not found with constant exposure to CORT in
the drinking water prior to LPS (Fig 3B & 3C; saline and LPS data from Fig 1B & 1C included
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Fig 2. Chronic CORT exacerbates LPS-induced neuroinflammation brain wide. The effects of chronic CORT pretreatment (200 mg/L 0.6% EtOH in drinking
water for one week) on LPS (2 mg/kg, s.c.)-induced TNFα, IL-6, CCL2, IL-1β, LIF, and OSM mRNA levels were measured in samples prepared from cortex (CTX),
hippocampus (HIP), striatum (STR), hypothalamus (HYPO), olfactory bulb (OB), and cerebellum (CB) 6 hours after LPS exposure. Data represents mean ± SEM
(n = 5 mice/group). Statistical significance of at least p<0.05 is denoted by  as compared to control, # as compared to LPS alone.
https://doi.org/10.1371/journal.pone.0190546.g002

for statistical comparison). These observations are consistent with our prior data for LPS [1]
where activation of STAT3 likely was not associated with activation of astrocytes, as we did not
observe an accompanying increase in GFAP (Fig 3B; saline and LPS data from Fig 1B included
for statistical comparison).

Chronic exposure to CORT exacerbates neuroinflammation induced by
another route of LPS exposure
Mice treated with CORT in the drinking water for 1 week were exposed to aerosolized LPS for
3 hours to determine if CORT affected the neuroinflammatory response to LPS via an alternate
route of exposure. Inhalation exposure to LPS alone did not affect expression of neuroinflammatory cytokines, but the prior exposure to CORT resulted in a marked increase in all cytokines, except IL-6 (Fig 4). Interestingly, mice that inhaled aerosolized water after a week of
CORT had a significantly elevated mRNA expression level of TNFα and slightly reduced IL-6
mRNA.
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Fig 3. Chronic CORT pretreatment exacerbates and prolongs LPS-induced neuroinflammation but has no effect on activation of STAT3 and does not cause
astrogliosis. A) A time course of LPS (2 mg/kg, s.c.)-induced neuroinflammation with and without CORT pretreatment (200 mg/L 0.6% EtOH in drinking water
for one week) is shown (saline, 2, 6 and 12 hours). TNFα, IL-6, CCL2, IL-1β, LIF, and OSM mRNA levels were measured in samples prepared from cortex. Data
represents mean ± SEM (n = 5 mice/group). CTX data for LPS alone treated groups are included from Fig 1A for statistical comparison. Statistical significance of at
least p<0.05 is denoted by  as compared to control, # as compared to LPS alone, § as compared to 2h CORT/LPS, and as compared to 6h CORT/LPS. B & C)
Effects of chronic CORT pretreatment (200 mg/L 0.6% EtOH in drinking water for one week) on LPS induced activation of the STAT3 signaling module was
assessed by immunoblots of pSTAT3Tyr705 and astrogliosis was assessed by immunoassay of GFAP. Cortex samples were analyzed for pSTAT3Tyr705 (6 hours) and
GFAP protein (72 hours) after LPS exposure of CORT pretreated animals. Data represent mean ± SEM (n = 5 mice/group). Saline and LPS alone treated groups are
included from Fig 1B & 1C for statistical comparison. Statistical significance of at least p<0.05 is denoted by  as compared to control, # as compared to LPS alone.
https://doi.org/10.1371/journal.pone.0190546.g003

Chronic exposure to CORT also exacerbates neuroinflammation induced
by the inflammagen, PIC
Similar to LPS, peripheral exposure to the viral mimic, PIC, is known to result in neuroinflammation throughout the brain [32–34]. As such, exposure to PIC alone caused a significant neuroinflammatory response at 6 hours post-exposure (Fig 5). Exposure to CORT in the drinking
water for 7 days significantly exacerbated the PIC-induced expression of cytokines and chemokines (Fig 5).
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Fig 4. Chronic CORT sensitizes the CNS to a sub-neuroinflammatory inhalation dose of LPS. Mice pretreated with CORT (200
mg/L 0.6% EtOH in drinking water for one week) were subjected to 3 hours of LPS (7.5 μg/m3) by inhalation. TNFα, IL-6, CCL2, IL1β, LIF, and OSM mRNA levels were measured in samples prepared from cortex collected immediately following LPS inhalation
exposure. Data represent mean ± SEM (n = 5 mice/group). Statistical significance of at least P<0.05 is denoted by  as compared to
respective control and # as compared to LPS alone exposed group.
https://doi.org/10.1371/journal.pone.0190546.g004
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Fig 5. Chronic CORT exacerbates PIC-induced neuroinflammation. Mice were pretreated with CORT (200 mg/L 0.6% EtOH
in drinking water for one week). TNFα, IL-1β, LIF, and OSM mRNA levels were measured in samples prepared from cortex
collected 6 hours after PIC exposure (12 mg/kg, i.p.). Data represent mean ± SEM (n = 5 mice/group). Statistical significance of at
least P<0.05 is denoted by  as compared to respective control group.
https://doi.org/10.1371/journal.pone.0190546.g005
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Single and recurring week-long exposures to CORT result in protracted
neuroinflammatory priming
While we have shown that a week-long exposure to high physiological levels of CORT in the
drinking water serves to potentiate the neuroinflammatory response to systemic LPS administration, the persistence and duration of this effect are unknown. To further define the effects of
CORT priming on the neuroinflammatory response to LPS, mice were exposed to CORT in
the drinking water for 1 week, but then not exposed to LPS until 30 days later. Even 30 days
after the cessation of exposure to CORT, the neuroinflammatory response remained primed to
exacerbate LPS-induced neuroinflammation (TNFα, CCL2, IL-1β) (Fig 6)(compare magnitude
of mRNA changes in this figure with those shown in Fig 3). However, an exacerbated neuroinflammatory response to LPS had dissipated by 90 days (Fig 7; CORT/LPS) after CORT treatment, as evidenced by the similarity in mRNA expression between CORT/LPS and LPS alone
treated groups. When mice were exposed to multiple, successive waves of 1-week exposures to
CORT over 90 days, however, the neuroinflammatory response to LPS was potentiated up to
10-fold greater than the response after a single 1-week CORT exposure prior to LPS (Fig 7;
CORT+++/LPS).

Discussion
We have demonstrated that exposure to CORT in the drinking water, at levels designed to
mimic high physiological stress levels of this hormone, markedly enhances the neuroinflammatory response to LPS and the viral mimic, PIC. This neuroinflammatory “priming” by
CORT is so effective that previously sub-neuroinflammatory exposures to LPS by inhalation
instigate significant neuroinflammation when combined with prior exposure to CORT. Furthermore, a single week of exposure to CORT in the drinking water maintains the potential for
priming the neuroinflammatory response to LPS for 30 days. Most remarkably, intermittent
exposure to 7 days of CORT for up to 90 days serves to markedly escalate the LPS-induced
neuroinflammatory response.
Neuroinflammation initiated by both neural damage and LPS is propagated through the
STAT3 signaling cascade [1,28]. However, while CORT primed the LPS-induced neuroinflammation, we found that the activation of STAT3 (pSTAT3Tyr705) was unaffected by prior CORT
exposure (Fig 3B). STAT3 activation due to neural damage is associated with astrogliosis and
subsequent elevations in the expression of the astrocyte intermediate filament protein, GFAP.
STAT3 activation caused by inflammagens such as LPS is not necessarily associated with neural damage [1] and, therefore, is not accompanied by an increase in GFAP (Figs 1 and 3).
Thus, the lack of an increase in pSTAT3Tyr705 or GFAP with CORT given prior to LPS suggests
that the CORT-induced exacerbation of LPS-induced neuroinflammation is not accompanied
by neural damage. The multiple cytokine pathways affected implicate involvement of microglia, to be explored in the future by more detailed analyses of components of the
inflammasome.
Previous studies have demonstrated a glucocorticoid-induced enhancement of neuroinflammation. An investigation that used CORT in the drinking water for a longer duration (10
days vs. the 7 days used here) evaluated the response of cultured primary microglia to LPS
exposure and found that microglia secreted more IL-1β, IL-6, and TNFα with longer CORT
pretreatment [17]. Using CORT pellets to mimic mild stress, adult adrenalectomized rats also
exhibited increased brain expression of TNFα and IL-1β, along with NF-κB activation [18]. In
a model of neuropathic pain, intrathecal administration of LPS 24 hours following a single
subcutaneous injection of CORT resulted in exacerbated LPS-induced allodynia and increased
expression of IL-1β and IL-6 in the spinal cord [19]. These studies combined with the work
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Fig 6. Chronic CORT pretreatment primes the neuroinflammatory response for 30 days. Mice were pretreated with CORT
(200 mg/L 0.6% EtOH in drinking water for one week). Thirty days after the cessation of CORT, mice were administered LPS (2
mg/kg, s.c.). TNFα, IL-6, CCL2, IL-1β, LIF, and OSM mRNA levels were measured in samples prepared from cortex 6 hours after
LPS exposure. Data represent mean ± SEM (n = 5 mice/group). Statistical significance of at least P<0.05 is denoted by  as
compared to appropriate control and # as compared to LPS alone.
https://doi.org/10.1371/journal.pone.0190546.g006
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Fig 7. Successive waves of CORT for 90 days greatly exacerbates LPS-induced neuroinflammation. Mice were treated with CORT
(200 mg/L 0.6% EtOH) for 7 days in the drinking water followed either by 90 days without (CORT) or 90 days of bimonthly, 7 day
CORT exposures (CORT+++). LPS (2 mg/kg, s.c.) was administered on day 97. TNFα, IL-1β, LIF, and OSM mRNA levels were
measured in samples prepared from cortex collected 6 hours after LPS exposure. Data represent mean ± SEM (n = 5 mice/group).
Statistical significance of at least P<0.05 is denoted by  as compared to appropriate control, # as compared to LPS alone, and § as
compared to CORT/LPS.
https://doi.org/10.1371/journal.pone.0190546.g007
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presented here illustrate that CORT exposure has the potential to exacerbate LPS-induced neuroinflammation both acutely and for a prolonged period (i.e., for 1–3 months, Figs 6 and 7).
We have expanded upon the results of previous studies by broadening the number of neuroinflammatory cytokines and chemokines examined, as well as by showing the altered kinetic
expression profiles of these genes following CORT pretreatment as well as the brain-wide
nature of the CORT-primed neuroinflammatory response. Additionally, our findings appear
to be the first to show an escalating priming effect on neuroinflammation at long-term time
points after episodic CORT exposures.
While chronic CORT exposure was used in this study to mimic high levels of physiological
stress, several others have shown that behavioral stress paradigms can also be pro-inflammatory. For example, a 2 hour repeated social defeat paradigm used in rats increased plasma IL1β levels in response to LPS administration [14]. Gibb et al. [35] found that both acute (social
disruption) or chronic (rotating stressor) stress paradigms prior to systemic LPS exposure
resulted in protracted sickness behavior and increased expression of cytokine mRNA in the
brain. Evaluation of these studies reveals that the repeated social defeat protocol used by Carobrez and colleagues [14] and the chronic stress paradigm used by Gibb and colleagues [35]
result in a greater increase in plasma CORT compared to other paradigms that were not found
to be proinflammatory [15,16]. These observations combined with our results clearly indicate
that the conditions of CORT exposure are a crucial factor in determining its pro-inflammatory
consequences. Furthermore, the variability of the responses to inflammatory challenge following stressor paradigms highlights the utility of our exogenous CORT exposure regimen, which
should, theoretically, produce a more uniform stress hormone response.
LPS stimulates the bacterial acute phase response of innate immunity, which is characterized by the release of inflammatory cytokines. Similarly, the synthetic dsRNA PIC instigates
the viral acute phase response. As the results of combining a stressor with PIC are mixed [36–
38], we exposed CORT-treated mice to PIC to test whether the CORT priming effect was generalizable to another inflammagen. Similar to LPS, the neuroinflammatory response instigated
by peripheral PIC exposure was exacerbated by prior exposure to CORT (Fig 5). This is particularly interesting because LPS and PIC have slightly different effects when administered
peripherally. First, LPS is a lipophilic compound that readily enters the bloodstream, gaining
access to the CNS to activate central neuroinflammation by binding to LPS receptors in the
brain [39]. However, intraperitoneally-administered PIC does not enter blood circulation and,
conversely, instigates neuroinflammation through peripherally-generated inflammatory mediators [40]. While it is possible that the mechanisms by which CORT pretreatment affects the
neuroinflammatory response to these two inflammagens may diverge, it is likely that CORT
exposure acts upon the overlapping signaling mechanisms induced by the peripherally-generated cytokines and chemokines following LPS or PIC exposure. This could be achieved
through modulation of neural cytokine/chemokine receptors or changes in the transport of
peripheral inflammatory mediators across the blood brain barrier by CORT. Second, LPS and
PIC signal through different receptors, with LPS signaling through Toll-like receptor 4 (TLR4)
and PIC signaling through Toll-like receptor 3 (TLR3), retinoic acid-inducible gene 1 (RIG1),
and melanoma differentiation-associated protein 5 (MDA5). The convergence on toll-like
receptor signaling between both of these inflammagens makes TLR signaling a viable candidate for further investigation into how CORT exposure instigates inflammatory priming. This
may result from effects on the LPS and PIC receptors directly, or indirectly through modulation of shared aspects of the inflammatory cytokine expression profiles instigated by these
inflammagens. Overall, the observation that CORT exacerbates LPS-induced and PIC-induced
neuroinflammation, as well as our prior observations with neurotoxicant exposures [1–4],
helps to build a library of disparate inflammatory conditions comprised of numerous signaling
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cascades which can be utilized and manipulated to discover a convergent mechanism by which
CORT exposure primes neuroinflammation.

Conclusion
Our findings confirm that prior exposure to CORT resembles the effects of behavioral stressors, several of which markedly increase neuroinflammation associated with a subsequent
innate immune system challenge with LPS. When this week-long prior exposure to CORT is
extended to multiple weekly episodes of CORT over three months, a dramatic escalation of the
neuroinflammatory response to LPS is seen, suggestive of the potential for chronic stressors to
cause long-lasting and severe neuroinflammation. Neuroinflammatory signaling serves as the
molecular basis for sickness behavior, symptoms of which are associated with chronic neurological disease states such as depression, chemobrain, neuropathic pain and Gulf War Illness
[3,4,41–43]. We conclude that there is the potential for recurrent physiological stressors to
contribute to and greatly exacerbate such chronic inflammatory disorders.
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